Vident Investment Advisory, LLC Jounce Therapeutics, Inc. Transaction History

Vident Investment Advisory, LLC

  • $0
  • Q3 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 14, 2018
SELL
$7.27 - $21.88 $972,907 - $2.93 Million
-133,825 Closed
0 $0
Q1 2018

May 14, 2018
BUY
$13.4 - $28.4 $487,210 - $1.03 Million
36,359 Added 37.3%
133,825 $2.75 Million
Q4 2017

Feb 15, 2018
BUY
$12.52 - $17.82 $333,382 - $474,510
26,628 Added 37.59%
97,466 $1.24 Million
Q3 2017

Nov 14, 2017
BUY
$11.17 - $16.99 $791,260 - $1.2 Million
70,838
70,838 $1.1 Million

Others Institutions Holding JNCE

# of Institutions
4
Shares Held
720K
Call Options Held
0
Put Options Held
0
View Full List

About Jounce Therapeutics, Inc.

JNCE Quotes by TradingView
  • Ticker JNCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,694,200
  • Description
  • Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...
More about JNCE
Track This Portfolio

Track Vident Investment Advisory, LLC Portfolio

Follow Vident Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Investment Advisory, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email